VeraSTAT – Enquiry

Home - Diagnostics

VeraSTAT – Enquiry

Excellence at the point of care, with accurate results in minutes


Largest COVID PCR testing provider announces new nationwide network of ‘adaptive’ labs

COVID-19 Testing        News        Contact Us

Tuesday 28 September 2021:  Largest COVID PCR testing provider announces new nationwide network of ‘adaptive’ labs

Randox, the UK’s largest laboratory diagnostics company, today announces its most significant expansion to date – the opening of 10 new adaptive “cube” laboratories within Great Britain. These facilities provide a rapid and cost-effective model to expand laboratory provision.   They will improve accessibility to Covid testing, facilitate wider screening services and adapt to future health and testing challenges.  Based on a modular format, sites can be operational within weeks and be redeployed if required.

The laboratories will initially be used to enhance the UK’s COVID-19 testing capacity during the winter, with each lab’s daily capacity of 12,000 tests combining to bring online an additional 120,000 COVID samples per day.  They can subsequently be re-purposed to meet the UK’s post COVID diagnostic requirements.

The opening of the new laboratories, which upon completion, will create 700 new jobs across the UK, follows £30 million of investment by Randox, bringing its total COVID-19 investment to £150 million. Two of Randox’s ten new labs are already operational outside Manchester, with two sites to the north of London opening before the end of the month. Following this, a further six labs are set to open by the end of 2021.

Commenting on the announcement Dr Peter FitzGerald, Randox Managing Director, said;

“Whilst the initial emphasis of these new laboratories will be on providing accessible, reliable and cost-effective COVID PCR tests, we of course acknowledge the positive steps being taken to ease restrictions and continue opening up our economy.

“We can draw on what we have learnt both pre and during COVID, leveraging the extensive logistics framework and IT infrastructure we have put in place, to directly address the global shortfall in laboratory testing capacity that has been exposed by the pandemic.

“The time taken to establish the required diagnostic infrastructure in the early stages of the pandemic adversely impacted the international response, but with such an adaptable capability, the UK can, as and when needed, respond rapidly to ever-increasing diagnostic demand.”

The new adaptive laboratories from Randox will ensure the provision of travel testing for those who still require them, and can also support any surge testing for the UK’s National COVID Testing Programme; Randox has processed and reported over 18 million COVID PCR samples to date.  Randox also facilitate Covid-19 lateral flow testing.

Having used its 40 years’ experience in diagnostics to focus the business towards COVID testing and support the fight against the virus, Randox, established in 1982, will subsequently use its new lab sites to service a wider UK system of walk-in clinics which can offer whole-body diagnostic screening programmes.

Dr FitzGerald continued;

“The legacy of COVID is that people increasingly understand and appreciate the importance of diagnostics and testing across our society, and as such we anticipate a real appetite from people to take greater interest in their health.

“We will continue COVID testing where necessary but will harness this high-volume testing capacity to pivot back to our core business offering of clinical health tests. The investment we have made in COVID lab facilities will allow us to build a national testing network that will facilitate a shift towards a new era of preventative healthcare, in which ill-health and disease are detected at the earliest possible opportunity, potentially even before symptoms appear.

“Our new adaptive laboratories will fundamentally be a game-changer for the UK’s future diagnostics requirements – improving patient outcomes and reducing the burden on healthcare services.”

 

For further information on Covid testing services please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com  or +44 (0) 28 9434 3005.

Want to know more?

Contact us or visit Randox Health.

Related COVID-19 Products and Services

PRE DEPARTURE

ANTIBODY TEST

DAY 2 TEST

LABORATORY TOOLS


Emerging SARS-CoV-2 variants: successful detection despite virus mutation

Randox Logo

02 February 2021

Test performance not affected by mutation found in new UK, South African and Brazilian variants.

The new SARS-CoV-2 variants that have been identified recently in the UK (known as 501Y.V1, VOC202012/01 or B.1.1.7 lineage), South Africa (known as 501Y.V2 or B.1.351 lineage) and Brazil (B.1.1.248 lineage), contain multiple mutations in the segment of the virus’ genome that codes for the spike protein.

Of particular interest is a double deletion at position 69-70 of the spike protein gene (69-70del), observed in the B1.1.7 variant, which has been found to affect the performance of some diagnostic PCR assays that use an S gene target (S gene dropout).

Detection of SARS-CoV-2 using the multiplex RT-qPCR assay from Randox Laboratories Ltd. is not affected by the identified mutations. This kit is a fast and highly sensitive multiplex diagnostic solution containing the necessary components to provide the detection of two genes (ORf I ab, E gene) to reduce the impact of genetic variation in the SARS-CoV-2 genome. The multiplex primer mix in this assay allows the amplification of specific gene sequences found within the genome of the pathogen, covering all variants. Therefore, the mutations in the B.I.I.7, B.I.351 and B.I.I.248 lineage variants do not affect the detection of SARS-CoV-2 by the PCR test.

Randox Laboratories Ltd. monitors SARS-CoV-2 variants in NCBI and GISAID databases and performs bioinformatics analysis regularly. Based on in silico analysis the performance of the test is not impacted by the mutations.

The Randox multiplex RT-qPCR diagnostic kit supports clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection, assisting the screening and isolation of individuals that require quarantine and immediate intervention.

Want to know more about Randox?

Contact us or visit our homepage to view more.

Our COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TRAVEL CERTIFICATE

LABORATORY TOOLS


Randox launches new COVID-19 testing facility at Heathrow Airport

Randox launches new COVID-19 testing facility at Heathrow Airport

27 January 2021: Randox launches new COVID-19 testing facility at Heathrow Airport

Global healthcare diagnostics company Randox Health has announced a new COVID-19 testing facility at Heathrow Airport.

The service from Randox, which is the largest COVID-19 testing provider in the UK and Ireland, and a partner in the UK Government’s National COVID-19 Testing Programme, uses gold standard PCR technology to generate results in 1 – 3 hours.

The laboratory is capable of processing up to 1000 samples per day, for both fit to fly and test to release, which allows individuals in England returning home from international travel to stop self-isolating if they get a negative test result after 5 days.

Dr Peter FitzGerald, Randox Founder and Managing Director commented;

“We continue to expand our portfolio of bespoke testing products and services, and our new testing facility at Heathrow Airport brings us one step closer to a timely return to a more normal society.

“It’s great to be able to provide our fit to fly and test to release services to the airport and help support their enormous efforts to restore public confidence in international travel and get people back in the air again.”

The Randox testing facility at Heathrow Airport runs in partnership with Doctap who provide a team of certified Sample Collection Officers to perform the swabbing on site.

A Laboratory Technician subsequently expedites the sample and reports the results, meaning that a fit to fly or test to release certificate that would normally take up to 48 hours now takes as little as 1 hour, and no longer than 3 hours to deliver a certificate back to a customer.

To book a test please visit Doctap.co.uk/randox or check out our London PCR Travel Test Sites here.

For further information on the Mobile Testing Laboratory please email mobiletesting@randox.com

 

Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.

Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).

COVID-19 antibody testing is available in Randox Health Clinics.

 

 

 

Want to know more about Randox?

Contact us or visit our homepage to view more.

Our COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TRAVEL CERTIFICATE

LABORATORY TOOLS


Randox approved for COVID-19 test to release scheme

RANDOX approved for COVID-19 test to release

21 December 2020: RANDOX approved for COVID-19 test to release

Randox has been added to the Department of Health and Social Care’s list of private providers of coronavirus testing.

This includes the lists for both general testing and test to release, a scheme which is applicable to those in England who need to self-isolate on their return from international travel.

If after 5 days you take a test and receive a negative result, you can stop self-isolating.

To purchase your COVID-19 test kit for test to release, visit; https://www.randoxhealth.com/covid-19-home-testing-kit-2/

Please Note: The earliest you can take the test is 5 full days after you left the country not on the travel corridor list. Individuals who do not opt into the Test to Release scheme will need to self-isolate until 10 full days have passed since they were last in a country not on the travel corridors list.

To opt into the scheme, visit https://www.gov.uk/provide-journey-contact-details-before-travel-uk

You must complete this form within 48 hours of arriving back in the UK and will require your booking reference number and name of the test provider.

To view the list of test and release testing providers, visit; https://www.gov.uk/government/publications/list-of-private-providers-of-coronavirus-testing/list-of-private-providers-of-coronavirus-testing

It is important to keep up to date with government guidelines by visiting https://www.gov.uk/guidance/travel-advice-novel-coronavirus to find out more.

For further information please contact covidcustomersupport@randox.com

Want to know more about Randox?

Contact us or visit our homepage to view more.

Our COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TRAVEL CERTIFICATE

LABORATORY TOOLS


Randox launches Mobile COVID-19 Lab for Workplace Testing

Randox launches Mobile COVID-19 Lab for Workplace Testing

11 December 2020: Randox launches Mobile COVID-19 Lab for Workplace Testing

World-leading diagnostics company Randox Laboratories has today unveiled a new Mobile Laboratory Service which will offer rapid and reliable COVID-19 workplace testing.

The service from Randox, which is the largest COVID-19 testing provider in the UK and Ireland, and a partner in the UK Government’s National COVID-19 Testing Programme, uses gold standard PCR technology to generate results in 1 – 3 hours.

Each Mobile Laboratory will be capable of processing up to 1000 samples per day, to allow employers to uphold COVID safety within the workplace and maintain maximum output.

Dr Peter FitzGerald, Randox Managing Director, said;

“As the nation continues to navigate the working challenges caused by the COVID-19 pandemic, an increasing number of organisations will want to implement a COVID-19 testing regime so that they can sustain safe working environments.

 “With this in mind we continue to expand our portfolio of bespoke testing products and services, and our latest addition, the Mobile Testing Laboratory, in conjunction with our work within the National Testing Programme, brings us one step closer to a timely return to a more normal society.”

As part of the Randox Mobile COVID-19 testing service, a team of healthcare professionals will collect the samples on site, and a Laboratory Technician will subsequently expedite the sample and reports the results.

The Mobile Laboratory is available across the UK from 14th December 2020.

Dr FitzGerald continued;

“Since a new study by researchers at the University College London revealed that 86% of people who tested positive for COVID-19 did not have virus symptoms1, frequent screening of asymptomatic patients, is vital to identify any hotspots and limit further spread.

 “Our Mobile COVID-19 Laboratory, which uses gold standard PCR technology and can visit the location of your choice for immediate service, will promote safe working practices, allow companies to demonstrate their commitment to their staff, and facilitate recovery of the UK economy.”

The Randox Mobile COVID-19 Laboratory comes fully staffed and stocked for testing, and is suitable for any and all industries – Construction, Aviation, Hospitality, Retail and more.

Find out more at https://www.randoxhealth.com/mobile-covid-19-testing-laboratory/

For further information please email mobiletesting@randox.com

 

References

    1 https://www.ucl.ac.uk/news/2020/oct/symptoms-covid-19-are-poor-marker-infection  

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our COVID-19 Products and Services

    HOME TEST

    ANTIBODY TEST

    TRAVEL CERTIFICATE

    LABORATORY TOOLS


    Randox launches €99 Express COVID-19 Testing Service at Dublin Airport

    Randox launches €99 Express COVID-19 Testing Service at Dublin Airport

    16 November 2020: Randox launches 99 Express COVID-19 Testing Service at Dublin Airport

    A 99 Express COVID-19 Testing Service which launches this week in a new Travel Testing Centre at Dublin Airport, will see the creation of 50 new jobs.

    The testing service from Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, utilises a robust and reliable method of testing known as PCR, which Junior Minister for Transport Hildegarde Naughton described as “the gold standard” for travel testing.

    The launch of the Randox Health Travel Centre, which offers rapid next day delivery of results for pre-departure screening as well as on-arrival testing to reduce quarantine timeframes, comes just after Ireland aligned itself with the new EU ‘traffic light’ system to co-ordinate international travel, on Sunday 8th November.

    Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, explained;     

     “With the introduction of the new EU traffic lights system, some people will need a COVID-19 test before travelling or equally, will want a negative test result simply for their peace of mind.

    “We are delighted to have secured a location at Dublin Airport, that allows us to extend our rapid and reliable COVID-19 Testing Service, already used by a range of well-known companies, airlines and elite sporting organisations, to individual passengers and consumers.”

    The Irish Government has agreed that, whilst those arriving from red zones currently have to quarantine for 14 days, this could soon be waived following a negative result from a COVID-19 PCR test taken five days after arrival in Ireland.

    Sophie continued;

    “Travel requirements during the pandemic continue to evolve, but with the introduction of the EU traffic light system, a common prerequisite to travel or to shorten existing quarantine periods will be a negative PCR COVID-19 test, which is currently the only method of COVID-19 testing recognised and approved by every country worldwide.

    “With significant capacity in place to implement high volume PCR testing, we welcome the opportunity to bolster the travel industry’s enormous efforts to restore public confidence in international travel.

    “We are committed to providing the most cost-effective and accurate test in the market to assist with the normalisation of travel, and so Randox will be opening a number of regional travel centres across Ireland over the coming weeks.”

    Dublin Airport Managing Director Vincent Harrison said the health and safety of passengers and staff had been the airport’s key priority during the pandemic and that continued to be the case;

    “We continue to operate a range of globally-recognised COVID-19 safety measures for the health and wellbeing of all airport visitors, and with the official opening of the Randox Health Travel Centre at Dublin Airport we can further support our passengers by offering them access to testing facilities onsite at the airport.”

    The Randox €99 Express COVID-19 Testing Service is open to all asymptomatic individuals and operates from the Randox Health Travel Centre beside Terminal 2 at Dublin Airport, as well as at a testing facility in Leopardstown Dublin.

    In the coming weeks Randox Health Travel Centres will also open in Galway, Limerick and Cork.

    Visit booking.randox.ie to book your appointment.

    For further information please email info@randoxhealth.com or phone 0800 2545 130.

       

      Want to know more about Randox?

      Contact us or visit our homepage to view more.

      Our COVID-19 Products and Services

      HOME TEST

      ANTIBODY TEST

      TRAVEL CERTIFICATE

      LABORATORY TOOLS


      New Express COVID-19 Testing Service with next day results launched in Dublin

      New Express COVID-19 Testing Service with next day results launched in Dublin

      06 November 2020: New Express COVID-19 Testing Service with next day results launched in Dublin

      A new express COVID-19 testing service has now launched in Ireland, with a rapid next day delivery of results.

      From global diagnostics provider Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, the service utilises a robust and reliable method of testing known as PCR, the only method recognized and approved for travel testing.

      The PCR testing, which Junior Minister for Transport Transport Hildegarde Naughton described as “the gold standard,” is available in Dublin for pre-travel clearance, or simply for those wanting a COVID-19 test for peace of mind.

      Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, explained;     

       “We appreciate that many people will want a COVID-19 test before travelling home this Christmas, or equally, will want a negative test result to reduce quarantine times and enable them to spend more time with loved ones.

       “PCR testing is currently the only method of COVID-19 testing which is recognised by every country worldwide. Our rapid, accurate and reliable testing service, used already by a range of well-known companies, airlines and elite sporting organisations, will help get plans off to a hassle-free start for travellers and non-travellers alike.”

      The launch of the Randox testing service comes just as Ireland aligns itself with the new EU ‘traffic light’ system to co-ordinate international travel, on Sunday 8th November.

      The Government has agreed that, whilst those arriving from red zones currently have to quarantine for 14 days, this could soon be waived following a negative test result from a COVID-19 test taken five days after arrival in Ireland.

      Sophie continued;

      “Travel requirements during the pandemic continue to evolve, but with the introduction of the EU traffic light system, a common prerequisite will be a negative PCR COVID-19 test prior to travel or to shorten quarantine periods.

      “We have significant capacity in place to implement high volume testing and with our PCR testing service, we look forward to supporting the travel industry’s enormous efforts to restore public confidence in international travel.”

      The Randox Express COVID-19 Testing Service is priced at €99, is open to all asymptomatic individuals and operates from the Clayton Hotel in Dublin.

      Visit booking.randox.ie to book your appointment.

      For further information please email info@randoxhealth.com or phone 0800 2545 130.

        Want to know more about Randox?

        Contact us or visit our homepage to view more.

        Our COVID-19 Products and Services

        HOME TEST

        ANTIBODY TEST

        TRAVEL CERTIFICATE

        LABORATORY TOOLS


        EU Traffic Light System: How to get a COVID-19 PCR test before travelling

        12 October 2020

        EU Traffic Light System: How to get a COVID-19 PCR test before travelling

        EU Traffic Light System: How to get a COVID-19 PCR test before travelling

        As Covid-19 infection rates continue to rise in many parts of the world, an increasing number of countries are asking for a negative PCR test as a means of proof that travellers do not have the Covid-19 virus.

        Whilst not yet a common requirement globally, it is understood that the EU could soon be turning to a Traffic Light System that will require pre-departure testing for individuals departing any of the 15 ‘red list’ countries – which includes the UK and could be extended to include Ireland.

        Whilst there are currently a number of countries across the EU that do not require a negative COVID test for visitors from the UK, the implementation of this co-ordinated approach across the EU will place common requirements on all travellers from the UK, no matter which country they are visiting.

        It could also be used in support of reduced quarantine in those countries which require it.

        So – what is a PCR test?

        PCR stands for Polymerase Chain Reaction and is a method of testing used to detect infectious disease, including COVID-19.

        A PCR test is performed in a laboratory and is indicative of an individual’s COVID status at the time their sample is taken. It does not show previous infection.

        Where can I get a COVID PCR test done?

        PCR tests are available at Randox Health via an in-clinic appointment, or a home sample collection.

        Are home tests accepted as proof of my COVID status?

        It is important to note that many countries do not accept ‘home tests’ as proof of a negative COVID-19 result. Results must show that the test was performed in a certified laboratory.

        Whilst Randox Health offers a home sample collection kit, all our testing is performed using PCR methods in our certified laboratories.

        If the country you are travelling to requires a PCR test result, we’ve got you covered.

        How do I know if I need a COVID PCR test?

        You can check the entry requirements for your destination at gov.uk/foreign-travel-advice

        Requirements are subject to change, so keep checking in the weeks and days leading up to your trip.

        When do I take my sample for testing?

        Your destination country will determine the time frame required for testing. For example, it may state that your sample needs to be taken and tested within 72 hours before departure / arrival. You cannot be swabbed before this time.

        It is best to book / order your test in advance and take it as early as possible within your window, so that you allow for the maximum amount of time to get your test results back.

        How long do I wait for my results?

        Upon receipt of sample at Randox’s laboratories, you will receive your results within 24 hours.

        Our rapid, accurate and reliable COVID-19 testing service will help get your trip off to a hassle-free start, with minimum disruption to your travel plans.

        Visit https://www.randoxhealth.com/covid-travel-certificate/ to order your home sample collection kit or book your clinic appointment.

        For further information please email info@randoxhealth.com or phone 0800 2545 130.

           

          Want to know more about Randox?

          Contact us or visit our homepage to view more.

          Our COVID-19 Products and Services

          HOME TEST

          ANTIBODY TEST

          TRAVEL CERTIFICATE

          LABORATORY TOOLS


          Randox selected to screen travellers to the UAE for Covid-19

          02 September 2020

          Randox selected to screen travellers to the UAE for Covid-19

          Randox Laboratories selected to screen travellers to the UAE for Covid-19, with six sample collection centres across the United Kingdom and Ireland

          Randox Laboratories has been selected by Pure Health, the largest laboratory network in the UAE, to test airline passengers flying into the United Arab Emirates, in accordance with the UAE’s requirement for travellers to prove they are not infected with Covid-19. Pure Health has been appointed by the UAE’s government to launch this pioneering project to promote safe travel.

          “We are delighted to support Pure Health in their efforts to control the Covid-19 pandemic and facilitate safe travels for passengers flying into the UAE,” said David Adamson, Randox Laboratories, Business Development Manager.

          “As one of the largest diagnostic facilities in UK, we are ideally placed to successfully deliver this ambitious initiative, and we are grateful for the trust placed in us.”

          Randox Laboratories has already set up six collection centres across United Kingdom and Ireland. The programme is already up and running in London, Liverpool, Glasgow, Belfast, Antrim and Dublin.

          “The UAE has trusted Pure Health with safeguarding it against any incoming Covid-19 threats, worldwide, this responsibility requires us to ensure we only partner with verified and accredited facilities around the world, thus why we have partnered with Randox Laboratories, to ensure that the screening process is of the highest quality and to ensure an excellent customer service for the travellers.” said Maria El Houari, International Passenger Screening Project Manager at Pure Health.

          The UAE issued regulations that require all travellers flying into the UAE to provide proof of a negative Covid-19 test. Travellers without such a certificate are refused entry into the flight.

          The system is similar to the ESTA process in the United States. The traveller visits screening.purehealth.ae, chooses a testing location, selects a time slot, and completes the test at the agreed time and place. Test results are then transmitted to the UAE authorities, who use the data to cross-check arriving travellers against the border control database.

            For further information please email randoxpr@randox.com

            Want to know more about Randox?

            Contact us or visit our homepage to view more.

            Our COVID-19 Products and Services

            HOME TEST

            ANTIBODY TEST

            TRAVEL CERTIFICATE

            LABORATORY TOOLS


            Request a meeting
            ×
            Make an Enquiry - RX series
            ×
            Make an Enquiry - Reagents
            ×
            Kit Insert Request - Reagents
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Kit Insert Request - Reagents
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - Reagents
            ×
            Make an Enquiry - Quality Control
            ×
            Make an Enquiry - RIQAS
            ×
            Make an Enquiry - RIQAS
            ×
            Make an Enquiry - Quality Control
            ×
            Make an Enquiry
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - Biochip
            • This field is for validation purposes and should be left unchanged.
            ×
            Make an Enquiry - Molecular
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            • This field is for validation purposes and should be left unchanged.
            ×
            Make an Enquiry - Future Diagnostics
            ×
            Make an Enquiry - RX series (Product)
            ×
            Make an Enquiry - Quality Control
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - RIQAS
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - Reagents
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Por favor, introduzca sus datos para ver nuestro último seminario
            ×
            Wyślij zapytanie
            • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje Polityki Prywatności.
            ×
            Wyślij zapytanie
            • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.